Concentration and pH Dependent Aggregation of Hydrophobic Drug Molecules and Relevance to Oral Bioavailability
- 26 February 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (6) , 1974-1983
- https://doi.org/10.1021/jm049439i
Abstract
We have examined selected physicochemical properties of compounds from the diaryltriazine/diarylpyrimidine (DATA/DAPY) classes of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and explored possible correlations with their bioavailability. In simple aqueous solutions designed to mimic the gastrointestinal (GI) environment of a fasting individual, all NNRTIs demonstrated formation of aggregates as detected by dynamic light scattering and electron microscopy. Under various conditions mimicking physiological transitions in the GI environment, aggregate size distributions were shown to depend on compound concentration and pH. NNRTIs with good absorption were capable of forming aggregates with hydrodynamic radii of ≤100 nm at higher concentrations and over wide ranges of pH, while poorly absorbed inhibitors form aggregates with radii of ≥250 nm at concentrations above 0.01 mM, probably representing precipitate. We propose a model in which the uptake rate into systemic circulation depends on having hydrophobic drug aggregates of appropriate size available for absorption at different locations within the GI tract.Keywords
This publication has 31 references indexed in Scilit:
- TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2004
- High‐throughput screening for stability and inhibitory activity of compounds toward cytochrome P450‐mediated metabolismJournal of Pharmaceutical Sciences, 2004
- TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimenAIDS, 2003
- A randomized, double-blind, placebo-controlled trial of TMC125 as 7-day monotherapy in antiretroviral naive, HIV-1 infected subjectsAIDS, 2003
- High-Throughput Screening in Drug Metabolism and Pharmacokinetic Support of Drug DiscoveryAnnual Review of Pharmacology and Toxicology, 2000
- Recent advances in buccal drug delivery and absorption — in vitro and in vivo studiesJournal of Controlled Release, 1999
- Oral particulate delivery: status and future trendsAdvanced Drug Delivery Reviews, 1998
- Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the RatJournal of Pharmaceutical Sciences, 1998
- Uptake and translocation of microparticles in small intestineDigestive Diseases and Sciences, 1995
- IAM chromatography: an in vitro screen for predicting drug membrane permeabilityJournal of Medicinal Chemistry, 1995